359 related articles for article (PubMed ID: 31595711)
1. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.
Jiang Z; Shen L; Wang S; Wu S; Hu Y; Guo J; Fu L
Cancer Med; 2019 Dec; 8(17):7278-7287. PubMed ID: 31595711
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
Fu L; Wu S; Yao T; Chen Q; Xie Y; Ying S; Chen Z; Xiao B; Hu Y
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493512
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA 0068669 as a new biomarker for hepatocellular carcinoma metastasis.
Yao T; Chen Q; Shao Z; Song Z; Fu L; Xiao B
J Clin Lab Anal; 2018 Oct; 32(8):e22572. PubMed ID: 29785842
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma.
Chen G; Xie D; Zhang P; Zhou H
Bioengineered; 2022 Jun; 13(6):14118-14124. PubMed ID: 35730467
[TBL] [Abstract][Full Text] [Related]
5. Global microarray profiling identified
Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Zhang C; Zhang C; Lin J; Wang H
Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
[TBL] [Abstract][Full Text] [Related]
7. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
Qi SX; Sun H; Liu H; Yu J; Jiang ZY; Yan P
World J Gastroenterol; 2019 Apr; 25(16):1964-1974. PubMed ID: 31086464
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
[TBL] [Abstract][Full Text] [Related]
9. Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma.
Kim G; Han JR; Park SY; Tak WY; Kweon YO; Lee YR; Han YS; Park JG; Kang MK; Lee HW; Lee WK; Kim D; Jang SY; Hur K
Sci Rep; 2021 Jul; 11(1):14930. PubMed ID: 34294754
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
Li X; Yang J; Yang X; Cao T
J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
[TBL] [Abstract][Full Text] [Related]
11. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development.
Shang X; Li G; Liu H; Li T; Liu J; Zhao Q; Wang C
Medicine (Baltimore); 2016 May; 95(22):e3811. PubMed ID: 27258521
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.
Fu L; Chen Q; Yao T; Li T; Ying S; Hu Y; Guo J
Oncotarget; 2017 Jul; 8(27):43878-43888. PubMed ID: 28410211
[TBL] [Abstract][Full Text] [Related]
14. circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Zhou C; Li R; Mi W
Ann Clin Lab Sci; 2020 Nov; 50(6):734-738. PubMed ID: 33334787
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of hsa_circ_0001649 in hepatocellular carcinoma predicts a poor prognosis.
Zhang X; Qiu S; Luo P; Zhou H; Jing W; Liang C; Tu J
Cancer Biomark; 2018; 22(1):135-142. PubMed ID: 29630526
[TBL] [Abstract][Full Text] [Related]
16. Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma.
Kang MK; Kim G; Park JG; Jang SY; Lee HW; Tak WY; Kweon YO; Park SY; Lee YR; Hur K
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895312
[TBL] [Abstract][Full Text] [Related]
17. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Cheng F; Wang L; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23300. PubMed ID: 32319701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
